Paramedical Exam Alternative: How Smartphone Scans Cut Vendor Costs
Paramedical exam alternatives using smartphone scans are cutting vendor costs for life insurers. Analysis of pricing, logistics, and where the industry is heading.

The paramedical exam alternative smartphone scan costs conversation has shifted from theoretical to operational. Five years ago, the idea of replacing a nurse visit with a 60-second phone camera scan sounded like a conference keynote pitch. Today, carriers are running the numbers on their vendor invoices, comparing them to what digital alternatives actually cost per applicant, and the gap is hard to ignore.
"86% of approved applications going through automated workflows were ultimately placed, compared to 78% for accelerated workflows and 63% for fully underwritten paths." — Gen Re, Individual Life Next Gen Underwriting Survey, 2025
What paramedical exams actually cost carriers
Most underwriting teams know their paramedical exam budget is significant, but the line-item breakdown tells a sharper story. A standard paramedical exam through vendors like ExamOne (a Quest Diagnostics subsidiary) or APPS-Portamedic runs between $100 and $200 per exam, depending on what is ordered. A basic blood draw and vitals collection sits at the lower end. Add a urine sample, EKG, or cognitive screening, and the price climbs.
But the vendor invoice is only part of the picture. The full cost of a paramedical exam includes scheduling coordination, no-show management, specimen handling and transport, lab processing, result delivery back to underwriting, and the time underwriters spend waiting for results before they can make a decision. Munich Re's analysis of accelerated underwriting programs found that the total cost of evidence gathering through traditional channels — including paramedics, APSs, and lab work — can reach $300 to $500 per application for fully underwritten cases.
Then there is the time cost. LIMRA data from their 2026 forecast report shows that carriers who reduced their cycle time through digital underwriting tools saw improved placement ratios. The logic is straightforward: the longer an applicant waits for a policy, the more likely they are to abandon the process or get picked off by a competitor.
| Cost component | Paramedical exam | Smartphone vitals scan |
|---|---|---|
| Vendor/technology fee per applicant | $100–$200 | $2–$10 |
| Scheduling and coordination | $15–$30 (staff time) | None (self-service) |
| No-show/reschedule rate | 10–20% | Near zero |
| Specimen transport and lab processing | $30–$60 | Not applicable |
| Average turnaround to underwriting | 5–14 days | Seconds to minutes |
| Applicant effort required | 30–60 minutes + travel | 60 seconds on phone |
| Total estimated cost per completed exam | $150–$350 | $2–$10 |
These are rough industry estimates, and they vary by carrier size, vendor contract, and geography. Rural exams cost more because examiners travel farther. High-net-worth cases with expanded panels cost more because of additional tests. But the magnitude of the gap between a $200+ paramedical and a sub-$10 digital scan is not something carriers can rationalize away indefinitely.
Why the vendor model was built for a different era
The paramedical exam infrastructure in the United States was designed for a time when there was no other way to get objective health data from an insurance applicant. You needed someone with phlebotomy training to draw blood, a chain-of-custody process for specimens, and a CLIA-certified lab to process results. The entire supply chain exists because, until recently, the only way to get biometric data was to physically collect biological samples.
APPS-Portamedic, now the largest paramedical services provider in the country, built their network of field examiners over decades. ExamOne expanded through Quest Diagnostics' infrastructure. These are real businesses with real employees driving to real homes and offices. And they have done a good job, by and large, of making the process work at scale.
The problem is not that paramedical vendors are bad at what they do. The problem is that the category of data carriers actually need for a growing percentage of their book has changed. For a $5 million policy on a 55-year-old with a complex medical history, a full paramedical with blood chemistry and EKG makes sense. The data density justifies the cost and the delay.
For a $250,000 term policy on a 35-year-old with no flagged conditions, clean MIB results, and a favorable prescription database check? The paramedical exam is collecting data that, in many cases, will not change the underwriting decision at all. The applicant was going to be approved at standard or preferred rates regardless. The exam just confirmed what the algorithmic triage already predicted.
This is the math that is pushing carriers toward smartphone-based alternatives for certain risk bands. Not replacing paramedicals entirely, but routing them more precisely to cases where the clinical data actually changes outcomes.
How smartphone vitals scanning works in an underwriting context
The technology behind smartphone-based health screening is remote photoplethysmography, or rPPG. The basic principle: when blood pulses through capillaries near the skin surface, it causes subtle changes in skin color that are invisible to the naked eye but detectable by a standard smartphone camera. Signal processing algorithms extract cardiovascular metrics from these color fluctuations.
A 2022 paper by researchers at the University of Toronto's Department of Electrical and Computer Engineering, led by Dr. Wenjin Wang and published in IEEE Transactions on Biomedical Engineering, demonstrated that rPPG algorithms could measure heart rate with mean absolute errors below 2 beats per minute under controlled conditions. Heart rate variability, respiratory rate, and blood oxygen estimates have also been validated in laboratory settings, though field accuracy varies with lighting and motion.
In an insurance workflow, the applicant receives a link during the digital application process. They open their phone camera, position their face in the frame, and hold still for 30 to 90 seconds. The system captures resting heart rate, heart rate variability (a marker of autonomic nervous system health), respiratory rate, and in some implementations, estimated blood pressure and oxygen saturation.
This is not the same data a paramedical exam collects. There is no blood chemistry, no cholesterol panel, no HbA1c. But for risk stratification purposes in the accelerated underwriting segment, the question is whether cardiovascular vitals data combined with third-party data sources (Rx checks, MIB, MVR, credit-based scores) provides enough signal to make a confident underwriting decision without sending an examiner.
Several carriers are answering yes, at least for lower face amounts and younger, healthier applicant pools.
The vendor cost structure under pressure
The economics of paramedical exam vendors are getting squeezed from both sides. On one end, carriers are routing fewer applicants to exams as accelerated underwriting programs expand. Gen Re's 2025 survey found that the majority of surveyed carriers now offer some form of accelerated or simplified underwriting pathway. Every applicant routed away from a paramedical is revenue the vendor does not earn.
On the other end, the cost of maintaining a national network of field examiners is not shrinking proportionally. Examiners need training, certification, insurance, and scheduling infrastructure. The fixed costs of the examiner network get spread across fewer exams, which puts upward pressure on per-exam pricing. It is a classic volume compression problem.
| Factor | Impact on exam vendors | Impact on carriers |
|---|---|---|
| Accelerated underwriting adoption | Lower exam volumes | Lower per-application costs |
| Examiner workforce aging | Recruitment difficulty, training costs | Longer scheduling wait times |
| Rural coverage gaps | Higher per-exam costs in underserved areas | Inconsistent applicant experience |
| Regulatory requirements (some states) | Continued demand for certain product types | Cannot fully eliminate exams |
| Smartphone vitals technology | Direct competition for routine cases | New evidence source at lower cost |
| Applicant expectations | Increased no-show rates | Abandonment and placement loss |
This does not mean paramedical vendors are disappearing. The complex case segment — high face amounts, older applicants, applicants with flagged conditions — still needs clinical-grade evidence. But the high-volume, low-complexity segment that used to be the bread and butter of the paramedical business is migrating toward digital alternatives.
What carriers are actually measuring with phone-based scans
The specific metrics a smartphone scan captures matter for underwriting decision-making, and it helps to be precise about what each one tells an actuary or underwriter.
Resting heart rate
Resting heart rate is one of the oldest and most reliable markers of cardiovascular fitness. The Framingham Heart Study, one of the longest-running epidemiological studies in history, has consistently shown that elevated resting heart rate correlates with increased all-cause mortality. A resting heart rate above 80 bpm carries measurably higher mortality risk than one below 65 bpm, even after adjusting for other risk factors. For life insurance underwriting, this is directly relevant to pricing.
Heart rate variability
HRV measures the variation in time between successive heartbeats. Higher variability generally indicates a healthier autonomic nervous system. Lower HRV has been associated with increased cardiovascular risk in studies published by researchers at the Harvard T.H. Chan School of Public Health, among others. For underwriting, HRV can serve as an early indicator of stress-related and metabolic conditions that might not yet show up in prescription databases or self-reported health histories.
Respiratory rate
Respiratory rate is less commonly used in traditional underwriting but provides useful data points. Elevated respiratory rate at rest can indicate respiratory conditions, anxiety disorders, or cardiac stress. It is one more signal that, combined with other data, helps an algorithm decide whether additional evidence is needed.
Blood pressure estimates
Some rPPG implementations include blood pressure estimates derived from pulse transit time analysis. This is the most debated metric in the rPPG space because blood pressure measurement via camera has higher variance than cuff-based readings. For underwriting triage purposes, though, even a rough blood pressure estimate can help identify applicants who should be routed to more thorough evaluation versus those who can proceed through an accelerated pathway.
Where the industry is headed
LIMRA's 2026 forecast projects continued growth in individual life insurance premiums, with technology and distribution expansion cited as key drivers. The report specifically notes that "advances in underwriting automation, digital applications, marketing, and lead generation have made the buying process faster and more accessible." That language maps directly to what smartphone-based screening enables: a faster, more accessible evidence-gathering step that does not require scheduling a stranger to come to your house.
The Send Technology 2026 insurance trends report identifies underwriting automation and alternative data sources as two of the top trends shaping the industry. The direction is consistent across reinsurer guidance, industry research, and carrier behavior: fewer paramedical exams for routine cases, more reliance on digital and algorithmic evidence gathering, and increasing use of biometric data captured directly from the applicant's device.
This is not happening overnight, and anyone who tells you paramedical exams will be gone in five years is overstating the case. Regulatory requirements in certain states still mandate specific evidence types for certain products. High-face-amount policies will continue to require clinical evidence. And carriers need actuarial experience data on digital alternatives before they can fully credit smartphone vitals in their pricing models.
But the trajectory is clear. The question for most carriers is not whether to adopt smartphone-based health screening — it is when, and for which segments of their book.
Frequently asked questions
Can a smartphone scan fully replace a paramedical exam?
Not for all cases. Smartphone scans capture cardiovascular vitals (heart rate, HRV, respiratory rate, blood pressure estimates) but do not provide blood chemistry, cholesterol, or urine analysis. For lower face amounts and healthier applicant pools, carriers are finding that phone-based vitals combined with third-party data sources provide sufficient evidence. Complex or high-value cases still benefit from clinical testing.
How much can carriers save by switching to smartphone scans?
The per-application savings depend on the carrier's current exam volume, vendor contract pricing, and which applicant segments they route to digital alternatives. A carrier spending $150 per paramedical exam on 100,000 applications annually could reduce that line item by 40–60% if half of those applicants qualify for a digital pathway instead. The indirect savings from faster placement and reduced abandonment are harder to quantify but often larger.
Are smartphone vitals accurate enough for underwriting?
Accuracy varies by metric and implementation. Heart rate measurement via rPPG has been validated in peer-reviewed research with mean absolute errors below 2 bpm under controlled conditions. HRV and respiratory rate measurements are reliable in good lighting conditions. Blood pressure estimates have wider variance. For underwriting triage — routing applicants to the right evidence pathway rather than making final pricing decisions — current accuracy levels are generally considered adequate.
What happens to paramedical exam vendors?
Paramedical vendors are adapting by focusing on the complex case segment where clinical evidence remains necessary, expanding into adjacent services, and in some cases developing their own digital capabilities. The vendor relationship is not disappearing — it is narrowing to higher-value, lower-volume work. Carriers with strong vendor relationships are typically negotiating new contract structures that reflect this shift.
Solutions like Circadify's smartphone-based vitals platform are built for exactly this kind of integration — providing carriers with objective biometric data at a fraction of the cost and turnaround time of traditional paramedical exams. For carriers evaluating their evidence-gathering strategy, internal linking to our analysis on digital versus traditional underwriting costs and our breakdown of rPPG technology in insurance provides additional context.
